Top Intrauterine Contraceptive Devices Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Intrauterine Contraceptive Devices Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Intrauterine Contraceptive Devices industry players.

Intrauterine Contraceptive Devices Market Competitive Landscape

​ The market for intrauterine contraceptive devices (IUD) is highly competitive with established vendors and new-generation companies. Bayer AG possesses the largest market share of approximately 35% because of its differentiated hormonal IUD portfolio, i.e., Mirena, Skyla, and Kyleena, which cater to different patient segments. Merck & Co. possesses the second with approximately 25% market share because of its strong business in hormonal and copper IUD markets, especially in emerging markets. Firms are emphasizing product innovation, i.e., concentrating on the development of small, flexible IUDs for nulliparous women and growing in emerging markets in strategic alliances and public education campaigns.

  • Medicine360: Founded in 2009, this not-for-profit pharma seeks to increase access to women's health. LILETTA, its lead product, is a hormone-releasing intrauterine device for 8 years of contraceptive use and treatment of heavy menstrual bleeding for up to 5 years. By selling it at a lower price through the 340B drug discount program, LILETTA allows Medicines360 to advance its goal of making contraception more affordable.

Top Player’s Company Profiles

  • Teva Pharmaceutical Industries Ltd. (Jerusalem)
  • Bayer (Germany)
  • EUROGINE (Spain)
  • CooperSurgical Inc. (US)
  • Pfizer Inc. (US)
  • HLL Lifecare Limited (Thiruvananthapuram)
  • OCON Medical Ltd. (Israel)
  • Prosan International BV (Netherlands)
  • Melbea Innovations (Hungary)
  • Allergan, Merck & Co., Inc. (US)
  • DKT International (US)
  • Medisafe Distribution Inc. (Canada)
  • Medicines360 (US)
  • Pregna International Limited (India)
  • Egemen International (Turkey)

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Intrauterine Contraceptive Devices Market size was valued at USD 4.6 Billion in 2024 and is poised to grow from USD 4.81 Billion in 2025 to USD 6.9 Billion by 2033, growing at a CAGR of 4.6% during the forecast period (2026–2033).

​ The market for intrauterine contraceptive devices (IUD) is highly competitive with established vendors and new-generation companies. Bayer AG possesses the largest market share of approximately 35% because of its differentiated hormonal IUD portfolio, i.e., Mirena, Skyla, and Kyleena, which cater to different patient segments. Merck & Co. possesses the second with approximately 25% market share because of its strong business in hormonal and copper IUD markets, especially in emerging markets. Firms are emphasizing product innovation, i.e., concentrating on the development of small, flexible IUDs for nulliparous women and growing in emerging markets in strategic alliances and public education campaigns. 'Teva Pharmaceutical Industries Ltd. (Jerusalem)', 'Bayer (Germany)', 'EUROGINE (Spain)', 'CooperSurgical Inc. (US)', 'Pfizer Inc. (US)', 'HLL Lifecare Limited (Thiruvananthapuram)', 'OCON Medical Ltd. (Israel)', 'Prosan International BV (Netherlands)', 'Melbea Innovations (Hungary)', 'Allergan, Merck & Co., Inc. (US)', 'DKT International (US)', 'Medisafe Distribution Inc. (Canada)', 'Medicines360 (US)', 'Pregna International Limited (India)', 'Egemen International (Turkey)'

Increasing uptake of long-acting reversible forms of contraception, including intrauterine contraceptive devices (IUDs), is one of the key market drivers. Women are increasingly opting for methods that are effective, low maintenance, and long-acting in preventing pregnancy. IUDs are over 99% effective and have a duration of 3–10 years, depending on the type, and hence provide a convenient option to short-term or daily contraceptives. Secondly, healthcare professionals actively prescribe LARC methods as a first-line contraceptive method and hence propel the use of IUDs. Awareness campaigns regarding the convenience and reliability of LARCs are leading to greater acceptability among various demographic and geographical segments.

Increasing Demand for Non-Hormonal Contraceptives: The demand for non-hormonal intrauterine contraceptive devices is increasing rapidly as more women opt for hormone-free options. Devices such as the Copper IUD are becoming popular due to their long-term nature but non-interference with hormonal balances. This trend is especially strong in those markets with consumers who are health-conscious and choose non-invasive, hormone-free products to escape side effects of hormonal birth control. The market is reacting to the need for more comfort and design in non-hormonal IUDs to meet this increasing demand, and they are now a competitive product on global markets.

North America dominates the worldwide intrauterine contraceptive devices (IUD) market based on enormous healthcare spends, universal insurance coverages, and continuous government promotion of family planning modes. Geographical focus on solutions to long-acting reversible contraception (LARC) and increased product technology advances for IUD have also benefited the growth process. Access by the leading participants and highly sophisticated existing healthcare systems are another benefit of the region. On top of that, a rise in awareness campaigns and educational programs has increased the popularity and use of IUDs among women, and North America emerged as a global market leader for the second time.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Feedback From Our Clients

Global Intrauterine Contraceptive Devices Market
Intrauterine Contraceptive Devices Market

Report ID: SQMIG35A3009

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE